Attana AB (NGM:ATANA)

Market Cap	48.27M
Revenue (ttm)	6.61M
Net Income (ttm)	-12.78M
Shares Out	1.38B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	251,478,430
Average Volume	69,497,835
Open	n/a
Previous Close	0.0140
Day's Range	n/a
52-Week Range	0.0050 - 0.1020
Beta	0.30
RSI	72.92
Earnings Date	Apr 30, 2025

About Attana AB

Attana AB provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia. The company offers analytical biosensor which allows studies on molecular interactions between proteins, DNA, and carbohydrates, as well as interactions to cells cultured; contract research services; and attana virus analytics. It serves academic institutions, biotech companies, and pharma companies. The company has a collaboration with the Linnaeus University. Attana AB was founded in 2002 and is headquartered in St...

• Industry: Commercial Physical and Biological Research
• Founded: 2002
• Employees: 10
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: ATANA

Financial Performance

In 2024, Attana AB's revenue was 6.61 million, a decrease of -3.02% compared to the previous year's 6.82 million. Losses were -12.78 million, -7.29% less than in 2023.